Austin Institute For Clinical Research

What Austin Institute For Clinical Research does

Austin Institute for Clinical Research is a dermatology-focused clinical research organization and wholly owned subsidiary of Sanova Dermatology, founded in 2013 and headquartered in Pflugerville, Texas. The company operates three research sites across Texas (Pflugerville, Dripping Springs, and Houston) and conducts Phase II–IV clinical trials in dermatology for pharmaceutical sponsors, biotechnology companies, contract research organizations, and medical device manufacturers. AICR has completed more than 200 studies, randomized over 4,000 patients across 26 dermatological indications, and is staffed by 4 principal investigators and 8 sub-investigators operating on shared CTMS and EDC infrastructure.

AICR generates revenue through professional services contracts with trial sponsors, with scope-of-work and contractual agreements governing study execution, patient recruitment, and data delivery. Its principal commercial differentiator is structural access to Sanova Dermatology's 11-location clinical practice and 50,000-patient base, which functions as a built-in referral pool for trial enrollment. The company has executed more than 10 medical device studies, including work with Sebacia, demonstrating capability beyond traditional pharmaceutical trials. Operationally, AICR combines site-level clinical execution with centralized trial management tooling across a small, multi-site Texas footprint.

Name

Austin Institute For Clinical Research

Legal name

Austin Institute For Clinical Research

Website

https://atxresearch.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Austin Institute for Clinical Research is a Texas-based dermatology-focused clinical trial site network and subsidiary of Sanova Dermatology. Founded in 2013, it runs Phase II–IV studies across 26 indications for pharma, biotech, CRO, and medical device sponsors, drawing on a 50,000-patient dermatology referral base.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417), Medical and Diagnostic Laboratories (62151)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

Keywords

• Dermatology clinical trials
• Clinical research services
• Phase II-IV studies
• Patient recruitment services
• Site management organization

Headquarters

HQ city

Pflugerville

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Clinical trial services for sponsors: AICR conducts Phase II through IV dermatology clinical trials for pharmaceutical companies, CROs, and medical device companies. Revenue is generated through contractual agreements for conducting clinical research studies, including patient enrollment, data capture, and regulatory compliance services.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Austin Institute for Clinical Research (AICR) is a dermatology-focused clinical research organization that conducts Phase II through IV clinical trials at three Texas-based study sites. AICR provides pharmaceutical sponsors, biotech firms, CROs, and medical device companies with study execution services including patient screening and enrollment, data capture, regulatory compliance, and centralized contracting and feasibility support, supported by four principal investigators and eight sub-investigators.

Product overview

Austin Institute for Clinical Research (AICR) is a dermatology-focused clinical research organization operating as a platform of clinical trial services across multiple study sites. The core offering consists of Phase II through IV dermatology clinical trials conducted by four principal investigators and eight sub-investigators at three locations (Pflugerville, Dripping Springs, and Houston, Texas). The platform integrates Site Support Services for centralized contracting, regulatory management, and feasibility studies, alongside Patient Recruitment Services leveraging Sanova Dermatology's 50,000-patient network. Therapeutic areas include acne, hidradenitis suppurativa, masseter muscle prominence, chronic pruritis, eczema, and psoriasis. The organization also offers device studies and utilizes Clinical Trial Management Software (CTMS) and electronic data capture (EDC) systems for trial administration.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Research Services Dermatology clinical trials (Phase II through IV) conducted across three Texas study sites with four principal investigators and eight sub-investigators, providing patient screening, enrollment, data capture, and regulatory compliance services for pharmaceutical sponsors, CROs, and medical device companies.
• Site Support Services Centralized team support overseeing all AICR trial locations, including contracting, regulatory documentation, feasibility studies, and coordination across multiple research sites, with digitized regulatory documents and simplified multi-site logistics.
• Patient Recruitment Services Recruitment services leveraging Sanova Dermatology's patient population of 50,000 patients, local and central advertising, database searches, physician/PA referrals, and sponsor-centralized ad campaigns to enroll trial participants across dermatology indications.

Quantifiable outcome

• 200+ dermatology studies completed across Phase II-IV
• +3 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Sanova DermatologycoreStrategic or Co-development PartnerAICR is a Sanova Dermatology company. Sanova Dermatology is the largest multisite research organization and private dermatology practice in the United States with 11 locations in two states, 50,000 total patients, 30 providers, and 10 research principal investigators. Sanova provides patient referrals and recruitment support for AICR clinical trials, while AICR provides Sanova with access to cutting-edge treatments and clinical research expertise.

Scale indicators9 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Proderm Research: A dermatology-focused CRO operating a multisite clinical trials network for cosmetic, skincare, and pharmaceutical dermatology studies. Highly comparable to AICR in therapeutic focus and site-network model.
• Therapeutics Inc. A dermatology and skincare-focused clinical research organization running Phase II–IV trials across multiple sites. Directly comparable in specialty focus and sponsor-customer base.

Broad incumbents

• ICON plc: One of the largest global CROs offering dermatology among many other therapeutic areas. Comparable as a competing site-network and full-service CRO for large pharma sponsors running dermatology programs.
• SGS Health Sciences: Global CRO providing clinical research services including dermatology trials. Comparable as a competing CRO serving pharmaceutical and medical device sponsors.
• Labcorp Drug Development (formerly Covance): Full-service CRO and central laboratory that conducts dermatology clinical trials. Comparable as a competing CRO offering central labs and site services to the same pharma and biotech sponsors.
• Worldwide Clinical Trials: Mid-size full-service CRO with therapeutic expertise including dermatology. Comparable as a sponsor-facing CRO competitor with Phase II–IV capabilities.
• MedPace: Mid-to-large full-service CRO that runs Phase II–IV dermatology trials among many other therapeutic areas. Comparable as a competing CRO for the same pharma/biotech sponsors, though much broader in scope.
• IQVIA: The world's largest CRO with extensive dermatology clinical trial capabilities and global site networks. Comparable as a competitor for sponsor trial allocation, though operating at much larger scale across all therapeutic areas.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/AICResearch
• LinkedInlinkedin.com/company/austin-institute-for-clinical-research

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Austin Institute For Clinical Research